https://doi.org/10.4081/monaldi.2023.2472
A case of hoarseness of voice following COVID-19 infection
Submitted: November 3, 2022
Accepted: December 27, 2022
Published: January 27, 2023
Accepted: December 27, 2022
Abstract Views: 897
PDF: 246
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Mucormycosis is a fatal angio-invasive fungal infection associated with a high mortality. Apart from the traditional risk factors, COVID-19 infection and steroid therapy for the same have been recently identified to predispose to this life-threatening infection. Usual presentations of mucormycosis include rhino-orbito-cerebral, pulmonary, gastrointestinal, renal and cutaneous involvement. We report an unusual case of mediastinal involvement by mucormycosis in a patient recovering from moderate COVID-19 pneumonia. Early diagnosis, prompt initiation of antifungal therapy accompanied by timely surgical debridement were pivotal in averting morbidity and mortality in this patient.
Prakash H, Ghosh AK, Rudramurthy SM, et al. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment. Med Mycol 2019;57:395-402.
DOI: https://doi.org/10.1093/mmy/myy060
Landstra CP, de Koning EJP. COVID-19 and diabetes: Understanding the interrelationship and risks for a severe course. Front Endocrinol 2021;12:649525.
DOI: https://doi.org/10.3389/fendo.2021.649525
Muthu V, Rudramurthy SM, Chakrabarti A, et al. Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world. Mycopathologia 2021;186:739–54.
DOI: https://doi.org/10.1007/s11046-021-00584-8
Hoenigl M, Seidel D, Carvalho A, et al. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe 2022;3:e543–52.
DOI: https://doi.org/10.1016/S2666-5247(21)00237-8
Rudramurthy SM, Hoenigl M, Meis JF, et al. ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries. Mycoses 2021;64:1028–37.
DOI: https://doi.org/10.1111/myc.13335
Dhooria S, Agarwal R, Chakrabarti A. Mediastinitis and bronchial perforations due to mucormycosis. J Bronchol Interv Pulmonol 2015;22:338–42.
DOI: https://doi.org/10.1097/LBR.0000000000000170
Connor BA, Anderson RJ, Smith JW. Mucor mediastinitis. Chest 1979;75:524–6.
DOI: https://doi.org/10.1378/chest.75.4.524
Liu HC, Jan MS, Lin YC, et al. A rare pulmonary zygomycosis manifested as chronic mediastinitis and bronchial perforation. Eur Respir J 2011;38:734–5.
DOI: https://doi.org/10.1183/09031936.00155110
Muthu V, Agarwal R, Patel A, et al. Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India. Lancet Infect Dis 2022;22:e240-53.
DOI: https://doi.org/10.1016/S1473-3099(22)00124-4
Cooper JD, Gotoff RA, Foltzer MA, et al. Mediastinal mucormycosis: Case report, review of literature and treatment with continuous liposomal amphotericin B irrigation. Mycoses 2019;62:739-45.
DOI: https://doi.org/10.1111/myc.12922
How to Cite
Joseph, Ruby, Kavitha Venkatnarayan, Ashitha Nanaiah, and Priya Ramachandran. 2023. “A Case of Hoarseness of Voice Following COVID-19 Infection”. Monaldi Archives for Chest Disease 93 (4). https://doi.org/10.4081/monaldi.2023.2472.
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Aladdin Bashir, Matthew Holmes, Nebumathew Suresh, Pedram Panahi, Sameh Atta, Hannah T. Perkins, Clinton Lloyd, Sanjay Asopa, The impact of COVID-19 prevention measures on surgical wound infection rates post-cardiac surgery , Monaldi Archives for Chest Disease: Vol. 94 No. 2 (2024)
- Emanuele Stirpe, Floriana Bardaro, Johanna Köhl, Unusual lymphadenopathy diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration , Monaldi Archives for Chest Disease: Vol. 93 No. 1 (2023)
- Aiswarya M Nair, Sowmya Gopalan, Vaasanthi Rajendran, Priyadarshini Varadaraj , Lakshmi Marappa , Viswanathan Pandurangan , Sudha Madhavan, Rajkumar Mani , Emmanuel Bhaskar , Role of secondary sepsis in COVID-19 mortality: Observations on patients with preexisting diabetes mellitus and newly diagnosed hyperglycemia , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Ravindra Nath, Neeraj Kumar Gupta, Amandeep Jaswal, Sparsh Gupta, Navjot Kaur, Santvana Kohli, Anirudh saxena, Pranav Ish, Rohit Kumar, Poornima Tiwari, Mukesh Kumar, Jugal Kishore, Geeta Yadav, Fellisha Marwein, Nitesh Gupta, Mortality among adult hospitalized patients during the first wave and second wave of COVID-19 pandemic at a tertiary care center in India , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Zehra Naseem, Muhammad Mussab Khakwani, Maaha Ayub, Ahmed Ayaz, Bushra Jamil, Ainan Arshad, SARS-CoV-2 induced coagulopathy and potential role of anticoagulation: Scoping review of literature , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Tobin P. Mangel, Brendan P. Madden, Acute tracheal tear – A potential cause of spontaneous pneumomediastinum in patients with COVID-19 , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
- Laura Bertacchini, Mara Paneroni, Laura Comini, Simonetta Scalvini, Michele Vitacca, Recovering of oxygenation, physical function and disability in patients with Covid-19 , Monaldi Archives for Chest Disease: Vol. 91 No. 4 (2021)
- Antonietta Coppola, Anna Annunziata, Maria Rosaria Gioia, Giuseppe Fiorentino, Bleeding events in COVID-19: the other side of the coin? , Monaldi Archives for Chest Disease: Vol. 91 No. 3 (2021)
- Parul Mrigpuri, Sonal Sonal, Sonam Spalgais, Nitin Goel, Balakrishnan Menon, Raj Kumar, Uncontrolled diabetes mellitus: A risk factor for post COVID fibrosis , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Nitesh Gupta, Pranav Ish, Rohit Kumar, Nishanth Dev, Siddharth Raj Yadav, Nipun Malhotra, Sumita Agrawal, Rajni Gaind, Harish Sachdeva, *Other members of the Safdarjung Hospital COVID 2019 working group, Evaluation of the clinical profile, laboratory parameters and outcome of two hundred COVID-19 patients from a tertiary centre in India , Monaldi Archives for Chest Disease: Vol. 90 No. 4 (2020)
You may also start an advanced similarity search for this article.
